82.7 F
New York
Friday, July 30, 2021

RedHill [NASDAQ: RDHL] Announces Partnership With Cosmo Pharma

Must read

Ucommune [NASDAQ: UK] Ink Cooperation Agreement with Beijing Investment Group

Ucommune International Ltd. inked a cooperation agreement with Beijing Investment Group Co., LTD. Beijing Investment is a fully state-owned land developer associated with...

Lion Electric [NYSE: LEV] all Set to Deliver Two Electric Trucks to Green Mountain Power

The Lion Electric Company revealed on Friday that it is preparing to deliver two of its all-electric trucks to Green Mountain Power (GMP)...

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

RedHill Biopharma Ltd. [NASDAQ: RDHL] disclosed Thursday it has partnered with Cosmo Pharmaceuticals. Both the companies entered into an agreement for exclusive licensing for multiple products.

After the agreement, RedHill & Cosmo will join hands to co-develop a novel next-generation therapy for the removal of H. pylori infection.

Shares of RedHill soared 2.45%, or up +0.22 during the trading of Wednesday. It had opened at $9.07 and has a previous close of $9.19. It has a day low and high range of $8.67-$9.37, respectively.

In the past 52-weeks of trading, its stocks have fluctuated between the low of $3.26 and a high of $10.17. RedHill has moved up 181.72% from its 52-weeks low and decreased -9.64% from its 52-weeks high.

If we look at the profitability of RedHill, its return on assets (ROA) is -64.50%. Its return on equity (ROE) is -125.20%, and return on investment (ROI) is-67.70%. Additionally, its Gross Margin is 36.60%.

Cosmo is to get Exclusive European right and planned to give $7 million to RedHill upon signing of the licensing agreement. Cosmo will pay an extra $2 million after receiving approval in Europe. The company also decided to pay 30% royalties.

Furthermore, RedHill and Cosmo decide to jointly conduct formally approved clinical trials in the US and Europe at the same time, at a cost split of 70% RedHill and 30% Cosmo.

Cosmo will become the manufacturer for the next-generation therapy for the removal of H. pylori infection, Movantik, and RHB-204 for pulmonary nontuberculous mycobacteria (NTM) infections.

More articles

Latest article

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...